Perturbation of the Human Microbiome as a Contributor to Inflammatory Bowel Disease

The human microbiome consist of the composite genome of native flora that have evolved with humanity over millennia and which contains 150-fold more genes than the human genome. A “healthy” microbiome plays an important role in the maintenance of health and prevention of illness, inclusive of autoimmune disease such as inflammatory bowel disease (IBD). IBD is a prevalent spectrum of disorders, most notably defined by Crohn’s disease (CD) and ulcerative colitis (UC), which are associated with considerable suffering, morbidity, and cost. This review presents an outline of the loss of a normal microbiome as an etiology of immune dysregulation and IBD pathogenesis initiation. We, furthermore, summarize the knowledge on the role of a healthy microbiome in terms of its diversity and important functional elements and, lastly, conclude with some of the therapeutic interventions and modalities that are now being explored as potential applications of microbiome-host interactions.

[1]  A. Khoruts,et al.  From stool transplants to next-generation microbiota therapeutics. , 2014, Gastroenterology.

[2]  L. Beutin,et al.  α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon , 2014, Gut.

[3]  F. Seibold,et al.  Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. , 2014, Gastroenterology.

[4]  Kori L Wallace,et al.  Immunopathology of inflammatory bowel disease. , 2014, World journal of gastroenterology.

[5]  G. Kaplan,et al.  The Increasing Weight of Crohn's Disease Subjects in Clinical Trials: A Hypothesis-generatings Time-trend Analysis , 2013, Inflammatory bowel diseases.

[6]  W. Petritsch,et al.  Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[7]  Anders F. Andersson,et al.  Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section , 2013, Gut.

[8]  C. Manichanh,et al.  Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.

[9]  J. Lewis,et al.  Analysis of the human gut microbiome and association with disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Patrice D Cani Gut microbiota and obesity: lessons from the microbiome. , 2013, Briefings in functional genomics.

[11]  Amjad Ali,et al.  Implications of the human microbiome in inflammatory bowel diseases. , 2013, FEMS microbiology letters.

[12]  Stefanie Wache,et al.  Evaluating the Quality of Colorectal Cancer Care across the Interface of Healthcare Sectors , 2013, PloS one.

[13]  Petra F. G. Wolffs,et al.  The human microbiome as a reservoir of antimicrobial resistance , 2013, Front. Microbiol..

[14]  R. Hunt,et al.  Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis , 2013, The American Journal of Gastroenterology.

[15]  S. Mazmanian,et al.  Disruption of the gut microbiome as a risk factor for microbial infections. , 2013, Current opinion in microbiology.

[16]  J. Guzman,et al.  Diet, Microbiome, and the Intestinal Epithelium: An Essential Triumvirate? , 2013, BioMed research international.

[17]  Ateequr Rehman,et al.  Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans , 2013, PloS one.

[18]  F. Guarner,et al.  Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission , 2013, Inflammatory bowel diseases.

[19]  Xin Wang,et al.  The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. , 2013, Diagnostic microbiology and infectious disease.

[20]  G. Gloor,et al.  Microbial ecosystems therapeutics: a new paradigm in medicine? , 2013, Beneficial microbes.

[21]  H. Schleibinger,et al.  Maintaining health by balancing microbial exposure and prevention of infection: the hygiene hypothesis versus the hypothesis of early immune challenge. , 2013, The Journal of hospital infection.

[22]  Richard T. Jaspers,et al.  Attenuated Increase in Maximal Force of Rat Medial Gastrocnemius Muscle after Concurrent Peak Power and Endurance Training , 2013, BioMed research international.

[23]  Elisabeth M. Bik,et al.  Distinct Distal Gut Microbiome Diversity and Composition in Healthy Children from Bangladesh and the United States , 2013, PloS one.

[24]  S. Ng,et al.  Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.

[25]  Curtis Huttenhower,et al.  A Guide to Enterotypes across the Human Body: Meta-Analysis of Microbial Community Structures in Human Microbiome Datasets , 2013, PLoS Comput. Biol..

[26]  Brian C. Thomas,et al.  Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization , 2013, Genome research.

[27]  Brandi L. Cantarel,et al.  Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease , 2012, PloS one.

[28]  Paul D. Cotter,et al.  Nucleic acid-based approaches to investigate microbial-related cheese quality defects , 2012, Front. Microbio..

[29]  A. Bitton,et al.  Inflammatory bowel disease: a Canadian burden of illness review. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[30]  Zhining Fan,et al.  Should we standardize the 1,700-year-old fecal microbiota transplantation? , 2012, The American journal of gastroenterology.

[31]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[32]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[33]  Shenglan Wang,et al.  Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease , 2012, Experimental and therapeutic medicine.

[34]  George M. Weinstock,et al.  Genomic approaches to studying the human microbiota , 2012, Nature.

[35]  E. Dempsey,et al.  High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin , 2012, Antimicrobial Agents and Chemotherapy.

[36]  S. Salminen,et al.  The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. , 2012, The American journal of clinical nutrition.

[37]  M. Blaser,et al.  Antibiotics in early life alter the murine colonic microbiome and adiposity , 2012, Nature.

[38]  A. Andoh,et al.  Terminal Restriction Fragment Length Polymorphism Analysis of the Gut Microbiota Profiles of Pediatric Patients with Inflammatory Bowel Disease , 2012, Digestion.

[39]  Y. Sanz,et al.  Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity , 2012, PloS one.

[40]  M. Neuman,et al.  Inflammatory bowel disease: role of diet, microbiota, life style. , 2012, Translational research : the journal of laboratory and clinical medicine.

[41]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[42]  T. Matsui,et al.  Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease , 2012, Journal of Gastroenterology.

[43]  D. C. Cara,et al.  Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. , 2012, The Journal of nutritional biochemistry.

[44]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[45]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[46]  L. McDonald,et al.  Infection control in the multidrug-resistant era: tending the human microbiome. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  P. Gionchetti,et al.  Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. , 2012, Gastroenterology.

[48]  R. Curi,et al.  Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.

[49]  P. François,et al.  Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue , 2011, Front. Microbio..

[50]  J. Clemente,et al.  Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.

[51]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[52]  A. Danoff,et al.  Energy, evolution, and human diseases: an overview. , 2011, The American journal of clinical nutrition.

[53]  P. Moayyedi,et al.  Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.

[54]  Julian Parkhill,et al.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.

[55]  P. Vandamme,et al.  Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.

[56]  K. Rioux,et al.  Influences of intestinal bacteria in human inflammatory bowel disease. , 2010, Infectious disease clinics of North America.

[57]  C. Bernstein,et al.  Association Between the Use of Antibiotics in the First Year of Life and Pediatric Inflammatory Bowel Disease , 2010, The American Journal of Gastroenterology.

[58]  N. Socci,et al.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.

[59]  Anders F. Andersson,et al.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.

[60]  J. Coffey,et al.  Desulfovibrio Bacterial Species Are Increased in Ulcerative Colitis , 2010, Diseases of the colon and rectum.

[61]  Michael A McGuckin,et al.  Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.

[62]  Henrik Svanström,et al.  Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.

[63]  E. Fattal,et al.  Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[64]  D. Relman,et al.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.

[65]  Minsoo Kim,et al.  Bacterial interactions with the host epithelium. , 2010, Cell host & microbe.

[66]  J. Doré,et al.  Intestinal Microbiota of 6-week-old Infants Across Europe: Geographic Influence Beyond Delivery Mode, Breast-feeding, and Antibiotics , 2010, Journal of pediatric gastroenterology and nutrition.

[67]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[68]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[69]  W. Michalski,et al.  Mycobacterium avium subspecies paratuberculosis in children with early‐onset Crohn's disease , 2009, Inflammatory bowel diseases.

[70]  J. Doré,et al.  Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.

[71]  J. Pitout IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora. , 2009, Current opinion in investigational drugs.

[72]  Hilary G. Morrison,et al.  Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation , 2009, Infection and Immunity.

[73]  K. Hunt,et al.  Coprophagy by the semi-habituated chimpanzees of Semliki, Uganda , 2008 .

[74]  I. Kaji,et al.  Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[75]  G. Radford-Smith,et al.  Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. , 2008, World journal of gastroenterology.

[76]  M. Abreu,et al.  TLR4 signalling in the intestine in health and disease. , 2007, Biochemical Society transactions.

[77]  R. Playford,et al.  NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease. , 2007, Journal of Crohn's & colitis.

[78]  W. Chamberlin Importance of the Australian Crohn's disease antibiotic study. , 2007, Gastroenterology.

[79]  F. Guarner Prebiotics in inflammatory bowel diseases , 2007, British Journal of Nutrition.

[80]  W. Selby,et al.  Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.

[81]  L. Peyrin-Biroulet,et al.  Antimycobacterial therapy in Crohn's disease: game over? , 2007, Gastroenterology.

[82]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[83]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[84]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[85]  F. Theissig,et al.  Comparative study of the intestinal mucus barrier in normal and inflamed colon , 2006, Gut.

[86]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[87]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[88]  T. Giese,et al.  High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease , 2005, Gut.

[89]  Clive M. Onnie,et al.  Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease , 2005, The Lancet.

[90]  E. Cario BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2 , 2005, Gut.

[91]  J. Reimund,et al.  Animal models of inflammatory bowel disease. , 2004, Journal of pharmacological and toxicological methods.

[92]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[93]  T. Borody,et al.  Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy , 2003, Journal of clinical gastroenterology.

[94]  F. Haesebrouck,et al.  Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria , 2003, Clinical Microbiology Reviews.

[95]  A. Concha,et al.  Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. , 2002, The Journal of nutrition.

[96]  H. Ogata,et al.  Animal models of inflammatory bowel disease , 2002, Journal of Gastroenterology.

[97]  R. Sartor,et al.  Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice , 2002, Inflammatory bowel diseases.

[98]  Jean-Frederic Colombel,et al.  Adherent Invasive Escherichia coli Strains from Patients with Crohn's Disease Survive and Replicate within Macrophages without Inducing Host Cell Death , 2001, Infection and Immunity.

[99]  G. Reid,et al.  Can bacterial interference prevent infection? , 2001, Trends in microbiology.

[100]  F. Shanahan,et al.  Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice , 2001, Alimentary pharmacology & therapeutics.

[101]  G. Jacobasch,et al.  Dietary resistant starch and chronic inflammatory bowel diseases , 1999, International Journal of Colorectal Disease.

[102]  K. Madsen,et al.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.

[103]  M. Kagnoff,et al.  Epithelial cells as sensors for microbial infection. , 1997, The Journal of clinical investigation.

[104]  F. Carbonnel,et al.  Effects of cigarette smoking on the long-term course of Crohn's disease. , 1996, Gastroenterology.

[105]  S. Hanauer,et al.  Double blind, placebo controlled trial of metronidazole in Crohn's disease. , 1991, Gut.

[106]  D. P. Strachan,et al.  Hay fever, hygiene, and household size. , 1989, BMJ.

[107]  J. Bennet,et al.  TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORA , 1989, The Lancet.

[108]  B. Huitfeldt,et al.  A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations. , 1982, Gastroenterology.

[109]  B. Huitfeldt,et al.  A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result. , 1982, Gastroenterology.

[110]  P. Guy Coprophagy in the African elephant (Loxadonta africana Blumenbach) , 1977 .

[111]  T. Jukes Antibiotics in Animal Feeds and Animal Production , 1972 .

[112]  S. Khanna,et al.  A clinician's primer on the role of the microbiome in human health and disease. , 2014, Mayo Clinic proceedings.

[113]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[114]  R. Farrell,et al.  Interactions Between Diet and Gut Microbes in Inflammatory Bowel Disease , 2013 .

[115]  A. Mizoguchi Animal models of inflammatory bowel disease. , 2012, Progress in molecular biology and translational science.